Lv1
60 积分 2021-06-04 加入
Surgical Intervention After Zolbetuximab-Based Chemotherapy for CLDN18.2-Positive Gastric and Gastroesophageal Junction Adenocarcinoma: A Case Series
1个月前
已完结
Targeting claudins in cancer
2个月前
已完结
Efficacy and safety of anti-CLDN18.2 therapies in advanced or metastatic gastric, gastro-oesophageal junction, and oesophageal carcinomas with CLDN18.2 positivity: a systematic review and meta-analysis
4个月前
已完结
KRAS-targeting PROTAC drug passes first clinical test
4个月前
已关闭
First-Line Tislelizumab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Cancer
4个月前
已关闭
Atezolizumab plus FOLFOX for Stage III Mismatch Repair–Deficient Colon Cancer
4个月前
已完结
PET/CT-guided management of immune checkpoint blockade and multi-modal profiling following treatment in long-term responders with metastatic lung cancer in the National Network Genomic Medicine Lung Cancer Germany (nNGM)
4个月前
已完结
Advances in the management of metastatic gastric cancer: current strategies and emerging therapeutics
5个月前
已完结
Advances in the management of metastatic gastric cancer: current strategies and emerging therapeutics
5个月前
已完结
Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline
5个月前
已关闭
皖公网安备34019202002308
